CBS 2019
CBSMD教育中心
中 文

Other Relevant Articles

Abstract

Recommended Article

Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease Future of Personalized Cardiovascular Medicine Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention Coronary Artery Calcium Progression Is Associated With Coronary Plaque Volume Progression - Results From a Quantitative Semiautomated Coronary Artery Plaque Analysis The Prognostic Value of Exercise Echocardiography After Percutaneous Coronary Intervention Comparison of Heart Team vs Interventional Cardiologist Recommendations for the Treatment of Patients With Multivessel Coronary Artery Disease Association of Coronary Anatomical Complexity With Clinical Outcomes After Percutaneous or Surgical Revascularization in the Veterans Affairs Clinical Assessment Reporting and Tracking Program

Review ArticleVolume 10, Issue 3, February 2017

JOURNAL:JACC: Cardiovascular Interventions Article Link

Management of No-Reflow Phenomenon in the Catheterization Laboratory

Rezkalla SH, Stankowski RV, Hanna J et al. Keywords: ST-segment elevation myocardial infarction; no-reflow; percutaneous coronary intervention

FULL TEXT PDF